Drug recall
NDC 64380-721-06 TACROLIMUS CAPSULES, USP 1mg 100 Capsules Rx Only Manufactured by: Strides Pharma Science…
FDA recall event 87027 · Class III · Strides Pharma Inc.
Key facts
| Event ID | 87027 |
|---|---|
| Recall numbers | D-0180-2021 |
| Recalling firm | Strides Pharma Inc. |
| Product type | Drugs |
| Products | NDC 64380-721-06 TACROLIMUS CAPSULES, USP 1mg 100 Capsules Rx Only Manufactured by: Strides Pharma Science Ltd. Bengaluru - 562106, India Distributed by: Strides Pharma Inc. East Brunswick, NJ 08816 |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Failed Moisture Limits |
| Initiation date | Dec 22, 2020 |
| Report date | Jan 6, 2021 |
| Termination date | Jan 26, 2022 |
| City | East Brunswick |
| State | NJ |
| Country | United States |
| FEI number | 3011707936 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: